INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

mRNA stability plays an important role in the expression of a wide range of eukaryotic genes (53). The steady-state concentration of a particular mRNA reflects a balance between its rates of synthesis and degradation. Each mRNA species decays at a characteristic rate (half-life [t_1/2]). Although the average t_1/2 of mRNAs in mammalian cells is 3 to 5 h (26), these values can range from several minutes, as for proto-oncogene and cytokine mRNAs (6, 53), to half a day or more, as for globin mRNAs (3, 54). In general, the t_1/2 of a specific mRNA correlates with the function of its protein product. Proteins that must be expressed in a narrow window of time are encoded by short-lived mRNAs, while proteins expressed in large quantities in terminally differentiated cells tend to be encoded by highly stable mRNAs (6, 52, 56, 64). The stability of an mRNA can also change in response to alterations in cellular growth conditions, environmental stress, cell cycle, or developmental cues (reviewed in references 2, 7, 45, and 46).

Determinants of mRNA stability are both general and specific and appear to act through multiple and frequently overlapping pathways. The vast majority of eukaryotic mRNAs share anm⁷G(5')ppp(5')N cap and a 3' polyadenylate [poly(A)] tail. These structures act, at least in part, to protect the mRNA from rate-limiting exonuclease attack. In yeast, 5' decapping is believed to be a rate-limiting step for the turnover of most mRNAs, followed by 5'3' exonucleolytic degradation (42, 43). This decapping is usually triggered by preceding shortening of the poly(A) tail (14, 15, 50, 58). Decapping can also be triggered directly, as appears to occur in the case of nonsense-mediated mRNA decay (43). Less commonly, mRNA degradation is initiated by site-specific endonucleolytic cleavage (8, 9). In a number of systems, these turnover pathways appear to be controlled by RNA-protein (RNP) complexes that assemble on the target mRNAs (31, 33, 49, 53). Although these complexes could theoretically assemble anywhere on the mRNA strand, the majority of relevant cis elements localize within the 3' untranslated region (3'UTR) (25).

Globin mRNAs serve as prototypes for long-lived mRNAs. Globin genes are expressed exclusively in cells of the erythroid lineage. Accumulation of globin mRNAs to well over 95% of total cellular mRNA during terminal erythroid differentiation reflects their unusual stability (4, 5, 32). Previous studies from our laboratory suggest that high-level stability of human -globin (h-globin) mRNA is conferred by sequences within its 3' UTR. Mutations that allow ribosomal read-through into this region destabilize h-globin mRNA, with consequent loss of gene function (11, 24, 35, 69). Our previous studies have mapped a discontinuous, pyrimidine-rich cis-acting stability element in the 3'UTR of h-globin (3'UTR) mRNA. Mutations in this element result in direct, translation-independent destabilization of h-globin mRNA in transfected mouse erythroleukemia (MEL) cells (70). More recent studies have demonstrated in vitro assembly of a sequence-specific RNP complex (-complex) at this site. This -complex is operationally defined by its characteristic migration on native gels and by its exquisite sensitivity to poly(C) competition. Mutations that block the in vitro assembly of the -complex also destabilize the -globin mRNA in transfected erythroid cells (68, 70). These data suggest that the -complex controls a rate-limiting step in mRNA degradation.

The -complex contains one or more proteins with poly(C) binding activity [-globin mRNA poly(C) binding protein (CP)] (30, 68). Biochemical studies demonstrate that this activity is encoded by at least three closely related CP isoforms: CP-1 and two forms of CP-2, the full-length protein (CP-2) and an alternatively spliced form lacking an internal 31-amino-acid segment (CP2-KL) (19). Each CP protein contains three repeats of a 50-amino-acid hnRNP K-homology domain (38, 60) that is present in a wide variety of RNA binding proteins (16, 18, 27, 36, 37, 44, 51, 57, 59, 61, 65). CPs can homodimerize as well as heterodimerize with other RNA binding proteins (references 19, 20, 26, 29, and 68a and our unpublished data). Both CP-1 and CP-2 can assemble into the -complex and in this respect appear to be equivalent in RNA binding (30). Whether CPs exists in the -complex as monomers or dimers and/or coassemble in the complex with additional protein partners is not known.

The ability to form the -complex does not appear to be erythroid cell specific, as this RNP complex can be assembled by using extracts from a wide range of cell types (22, 41, 68). Consistent with this observation is the demonstration that CPs have a wide tissue distribution (1, 22). These data suggest that CPs and/or the proteins that constitute the -complex have broad functions that extend beyond stabilization of h-globin mRNA. A subset of highly stable mRNAs that share with h-globin mRNA a pyrimidine-rich motif in their 3'UTRs have been identified (22). These mRNAs, which include 15-lipoxygenase (Lox) (47), 1(I)-collagen (Coll) (63), and tyrosine hydroxylase (TH) (13), each assemble a complex at the pyrimidine-rich regions of their 3'UTRs, and each of the in vitro-assembled complexes contains CPs (22). In the case of TH and Coll, the high-level stability of the mRNA has been linked to this cis element (13, 63). These data have led to the model that CP-containing complexes constitute general determinants of mRNA stability (22).

Whether the CPs alone constitute the -complex is unclear. While biochemically enriched CP proteins can reconstitute -complex formation in a cytosolic extract depleted of poly(C) binding activity, they do not appear to bind directly to the -globin mRNA 3'UTR (30, 68). This finding has suggested that assembly of CPs into the -complex may depend on their interaction with other proteins during complex formation. The presence of coassembling proteins is suggested by the identification of a number of proteins that interact with CPs by yeast two-hybrid screens (references 19, 29, and 68a and our unpublished results). One of these proteins, AU-rich binding factor 1 (AUF1; also referred to as hnRNP D [28]), has previously been implicated in accelerated decay of immediate-early mRNAs with AU-rich cis elements in their 3'UTRs (17, 66, 72). This same AUF1 was recently identified as one of multiple proteins that comigrate on a native gel with the in vitro-assembled -complex (29). On the basis of that study, it was proposed that AUF1 constitutes a component of the -complex. Separate studies suggest that CP may interact with a second poly(C) binding protein, hnRNP K, at the pyrimidine-rich element within the 3'UTR of the long-lived erythroid cell-specific Lox mRNA (48). This complex formation has been implicated in translational control of the Lox mRNA (47). There is no direct evidence to confirm the incorporation of AUF1, hnRNP K, or any other proteins into the -complex. The composition and stoichiometry of the proteins in these complexes and their mode of action as determinants of mRNA function remain to be determined. The present study focuses on these questions. The data suggest a simple binary model of -complex structure.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Cell extracts. Human erythroleukemia (K562) and MEL cells were cultured under standard conditions (68). Cell fractionation and preparation of cytosolic extracts (S100) were as previously described (23, 68).

Expression of recombinant CPs. Vectors, buffers, and protocols used for expression of CPs were purchased from Qiagen and Novagen (vector DNA pET-28a). In brief, the coding regions for hCP-1, hCP-2, and mouse CP2-KL (mCP2-KL) (19, 30, 34) were PCR amplified from plasmids pGBD-CP1, pGBD-CP2 (gifts from M. Kiledjian, Rutgers University, New Brunswick, N.J.) (29), and pB1005 (a gift from S. Smale, University of California, Los Angeles) (21), respectively. The gel-purified PCR products were cloned into pET-28a (hCP-1), pQE-31 (hCP-2), and pQE-8 (mCP2-KL), and the fusion proteins were expressed, purified on Ni²⁺ columns (Novagen), and further purified over a Superdex 200 gel filtration column (Pharmacia). The major column peak, containing the monomeric form of recombinant CP, was used for RNA binding studies. The concentrations of purified recombinant His₆-CPs were calculated by the Bradford method and verified by comparison with dilutions of ovalbumin, using silver-stained sodium dodecyl sulfate (SDS)-polyacrylamide gels. The recombinant hCP-1 expressed from the pET-28a vector contained an additional vector-derived 34 amino acids, while hCP-2 and mCP2-KL expressed from the pQE series vectors contained an additional 10 vector-derived amino acids.

RNA probes. 3'UTR transcription templates were generated by PCR from the wild type h-globin gene or from h-globin genes containing specific 3'UTR mutations (40). Transcription of each full-length 3'UTR was carried out with the amplified fragments as previously reported (68). RNA oligonucleotide probes corresponding to pyrimidine-rich segments within the 3'UTRs of rabbit Lox (47), human Coll (63), rat TH (13), PR (the 42-nucleotide [nt] RNase-protected region of the 3'UTR protected by the assembled -complex [22]), and the mutated form of PR are all as previously reported (22). RNA oligonucleotides were synthesized by the University of Pennsylvania Nucleic Acid Core Facility. Probes were 5'-end labeled by using T4 polynucleotide kinase (New England Biolabs Beverly, Mass.) and [-³²P]ATP (Amersham).

EMSA. The RNA electrophoretic mobility shift assay (EMSA) was carried out as described previously (23, 68). RNA probe (~20,000 cpm) was incubated with 50 µg of S100 proteins (or ~50 ng of His₆-CP-1, His₆-CP-2, or His₆-CP2-KL purified protein) in a 20-µl total volume at room temperature for 30 min. Binding buffer was 10 mM Tris-HCl (pH 7.4), 150 mM KCl, 1.5 mM MgCl₂, and 0.5 mM dithiothreitol. RNase T₁ (1 U/µl) was then added, and the mixture was incubated first at room temperature for 10 min and then for additional 10-min incubation in the presence of added heparin (final concentration, 5 mg/ml; Sigma). Samples were subsequently electrophoresed through a 5% nondenaturing polyacrylamide gel in 0.5× Tris-borate-EDTA buffer. Bands were visualized by autoradiography of the dried gel. For EMSA with ³²P-labeled synthetic oligonucleotide, 20,000 cpm of probe was mixed with 50 µg of MEL S100 extract (or ~50 ng of His₆-CP-1, His₆-CP-2, or His₆-mCP2-KL purified protein), incubated, and then gel analyzed as detailed above except that RNase T₁ digestion was omitted.

Protein recruitment assay. S100 extract (80 to 100 µg) was preincubated with 0.5 µl of -mercaptoethanol (-ME) and 1.0 U of RNase inhibitor (purchased from 5' Prime3' Prime) for 20 min at room temperature. The extract was then added to a mixture of 30 µg of tRNA, 17 µl of 4× binding buffer (600 mM KCl, 6 mM MgCl₂, 40 mM Tris-HCl [pH 7.4], 2 mM dithiothreitol), and 20 ng of [³²P]3'UTR. The incubation mixtures also contained 0, 20, or 40 µg of unlabeled 3'UTR in a final volume of 60 µl. After 20 min of incubation at room temperature, RNase T₁ (1 U/ml) was added and the mixture was incubated at room temperature for an additional 10 min. Glycerol loading dye containing 200 µg of heparin was added, and equal aliquots of each sample were immediately loaded onto four separate 5% acrylamide-0.5× Tris-borate-EDTA gels and run at 110 V for 3 h. One gel was dried and autoradiographed, while the other gels were transferred to nitrocellulose filters and separately probed or stripped and reprobed with the one of the following five antibodies. The chicken anti-CP (used at 1:5,000 dilution) lacks isoform specificity (22); mouse monoclonal antibody 3C2 (1:20,000 dilution; gift from G. Dreyfuss) is specific for hnRNP K and J (38); rabbit anti-AUF (used at 1:15,000 dilution) was a gift from G. Brewer, anti-CP-1 recognizes CP-1 but not CP-2; anti-CP-2 recognizes full-length CP-2 but not CP-1 or CP2-KL. The latter two rabbit antisera (used at 1:6,000 dilutions) were kind gifts from A. Gamarnik, University of California, San Diego (20). To generate sufficient amounts of the anti-CP-1 and anti-CP-2 antibodies for all experiments, additional rabbit antisera (lab designations FF1 and FF2) were raised by our laboratory against the same two epitopes as originally described (20) (residues 229 to 243 in the CP-1 sequence and residues 200 to 214 in the CP-2 sequence, respectively). An antibody that recognized CP2-KL was also generated. This antiserum (lab designation FF3) was raised against an epitope (residues 237 to 251 in the CP-2 sequence) that was common to CP-2 and CP2-KL and distinct from CP-1. After electrotransfer of proteins and incubation of the membrane with primary antibodies, the signals were developed by incubation with appropriate secondary antibodies: horseradish peroxidase-conjugated goat anti-chicken immunoglobulin G (IgG; used at 1:7,000 dilution; Accurate Chemical, Westbury, N.Y.), sheep anti-mouse IgG (used at 1:5,000; Amersham), or donkey anti-rabbit IgG (used at 1:5,000; Amersham). Immune complexes were detected by using the Amersham ECL system.

Reverse transcription (RT)-PCR analysis. Total cytoplasmic RNA was isolated from MEL and K562 cells by the phenol-detergent method (39). First-strand cDNA was synthesized with 10 U of avian myeloblastosis virus reverse transcriptase (Promega), using 1 µg of the total cytoplasmic RNA and 10 pmol of random hexanucleotide primers (Boehringer Mannheim). Double-stranded DNA was then generated by PCR amplification with Taq DNA polymerase (Perkin-Elmer), using a ³²P-end-labeled antisense primer (5'-CAA TAG CCT TTC ACC TCT GGA GA-3') and an unlabeled sense primer (5'-CRT GAC CAT YCC GTA CC-3'). Conditions for PCR were as follows: preheating at 95°C for 3 min, denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for 2 min. Samples were taken after 24 to 32 PCR cycles and applied to 2.5% MetaPhor agarose (FMC) gel. The dried gel was analyzed with a PhosphorImager (Molecular Dynamics), and the radioactivity in each band was determined by using ImageQuant software. The ratio of the different bands was calculated as described from the slope of the line comparing PCR products to the number of PCR cycles (62).

RNA-binding affinities. Concentrations of CP in MEL S100 cytoplasmic extract were normalized to the concentration of recombinant CP by Western blot analysis with the chicken anti-CP. RNA-protein binding reactions were carried out by addition of increasing concentrations of protein to a constant RNA concentration. Bound and free RNAs were separated by EMSA (see above), gels were dried, and band activities were quantified by PhosphorImager analysis. Free probe concentrations were plotted versus the relative concentration of His₆-CP2-KL, His₆-CP-1, or His₆-CP-2 or the concentration of CP in extract. Relative affinities (Fig. 7A to C) were determined as the protein concentration at which 50% of the RNA was bound (10). Absolute values of apparent K_d for the 3'UTR (Fig. 7D) were measured as described elsewhere (55), with minor modifications, by titration of the 3'UTR probe.

Sucrose gradient centrifugation. Ninety-microliter aliquots of MEL cell S100 extract (1 mg of total protein) or purified recombinant His₆-CPs (30 µg) were incubated for 20 min at room temperature in the presence of 2% -ME and 2 U of RNase inhibitor (5' Prime3' Prime). Samples were mixed with 50 µl of binding buffer supplemented with 70 µg of yeast tRNA and 4 × 10⁷ cpm of ³²P-labeled 3'UTR probe and incubated for additional 20 min at room temperature. An identical mixture in which no probe had been added was prepared in parallel. The mixtures were treated with 150 U of RNase T₁ for 5 min, and heparin was added to the final concentration of 2 mg/ml. Samples were loaded onto prechilled 5 to 20% sucrose gradients made in binding buffer and supplemented with 1.5% (vol/vol) -ME, 2 mg of heparin per ml, 10 µg of leupeptin per ml, 1 µg of pepstatin A per ml, and 2 µg of aprotinin per ml. Gradients were centrifuged in an SW41 rotor at 37,000 rpm for 40 h at 4°C and fractionated from the top. Gradients of S100 extract lacking RNA probe were analyzed for the presence of CP by Western blot analysis with chicken anti-CP antibodies (1:5,000 dilution) and for the ability to reconstitute the -complex by addition of 2 × 10⁵ cpm of ³²P-labeled 3'UTR to 20-µl aliquots of the gradient fractions followed by EMSA. Mobility standards were myoglobin (M_r = 17,000, s_20,w = 2.04), ovalbumin (M_r = 43,000, s_20,w = 3.66), bovine serum albumin (BSA) (M_r = 67,000, s_20,w = 4.58), and aldolase (M_r = 158,000, s_20,w = 7.35). Peaks were revealed and quantified by exposure of the gels to a PhosphorImager screen (Molecular Dynamics). All data were within the linear range and were analyzed with ImageQuant software (Molecular Dynamics). Sedimentation coefficients (S values) for CPs and -complex were determined from the linear curves for the isokinetic gradient.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

CPs are quantitatively recruited into the -complex in the absence of associated AUF-1 or hnRNP K. Previous studies have suggested that the 37-kDa AU binding factor AUF1 and the 69-kDa hnRNP K may associate with CP in RNP complexes (29, 48). To directly test for these two proteins in the -complex, we carried out a series of RNP recruitment assays (Fig. 1). In these assays, increasing concentrations of a specific 3'UTR RNA target were added to S100 extract followed by RNase digestion and electrophoresis on a native gel. If a protein bound to the added RNA, it would be shifted (recruited) from its uncomplexed position on a native gel to a position corresponding to the resultant RNP complex. Tracer levels of ³²P-labeled -complex, generated in a manner identical to that used for the parallel recruitment reactions, were used to mark the position of this complex (Fig. 1A). Recruitment of each protein in question (CPs, AUF1, or hnRNP K) was selectively monitored by Western analysis of the recruitment gel by using the corresponding antibody. Addition of increasing amounts of unlabeled 3'UTR probe resulted in a quantitative recruitment of CPs to the -complex (Fig. 1B). At levels of mRNA sufficient for full recruitment of all immunoreactive CPs, there was no corresponding shift in the migration of either hnRNP K or AUF1 from its native positions (Fig. 1C and D, respectively). The presence of both CP-1 and CP-2 in the -complex was specifically demonstrated by reprobing the Western blots with epitope-specific antisera (Fig. 1E and F, respectively). These data demonstrated that a spectrum of CPs was quantitatively incorporated into the -complex in the absence of AUF1 and hnRNP K. 

View larger version (61K): [in this window] [in a new window]   FIG. 1.   Selective recruitment of CP into the -complex. (A) Position of the -complex. The -complex (as indicated) was identified by incubating MEL cytosolic S100 extract with [32P]3'UTR followed by RNase treatment. The sample was electrophoresed on a native polyacrylamide gel and autoradiographed. (B) Recruitment of -CP into the -complex. Increasing concentrations of unlabeled 3'UTR (indicated by the wedge; see Materials and Methods for concentrations) were incubated with MEL S100 extract to form the -complex. Products of the incubations were analyzed on native gels. The position of the uncomplexed CP in the S100 and its recruitment to the position of the -complex were each visualized by Western analysis. (C) AUF1 was not recruited into the -complex. AUF1 was detected with a monospecific antibody (gift from G. Brewer). The study was carried out as for panel B. (D) hnRNP K was not recruited into the -complex. hnRNP K was detected with a corresponding monospecific antibody (38). The study was carried out as described above. (E) Recruitment of CP-1 into the -complex (determined as detailed for panel B). The antibody used was specific to the CP-1 isoform (see Materials and Methods and Fig. 6A). (F) Recruitment of CP-2 into the -complex (determined as detailed for panel B). The antibody used was specific to the CP-2 isoform (see Materials and Methods and Fig. 6A).

Quantitative recruitment of CPs into the Lox mRNA 3'UTR complex in the absence of associated hnRNP K. hnRNP K has been specifically reported to associate with CPs in the translational-silencing RNP complex that forms at the pyrimidine-rich motif of the Lox mRNA 3'UTR (48). Because hnRNP K was not observed to coassemble with CP in formation of the -complex (Fig. 1C), the recruitment assay was extended to analyze the complex forming on the Lox 3'UTR (Fig. 2). A position marker for the Lox complex was established by incubating tracer amounts of ³²P-labeled Lox 3'UTR with S100 extracts. As expected on the basis of previous studies (22), this complex was sensitive to poly(C) competition (Fig. 2A). Addition of unlabeled Lox 3'UTR to the extract resulted in quantitative recruitment of CP to the position of the Lox complex (Fig. 2B). Although there was a gradual downward shift in the position of hnRNP K with the addition of increasing amounts of Lox mRNA, this change appeared to be nonspecific, as the band remained well above the position of the Lox complex, as marked by the radioactive RNA probe and the coincident position of the recruited CP (Fig. 2C). Thus, CP was identified in the Lox complex, consistent with our prior studies (22), but hnRNP K could not be detected in the same complex.

View larger version (48K): [in this window] [in a new window]   FIG. 2.   Recruitment of CP but not hnRNP K into the Lox 3'UTR complex. (A) Identification of the Lox complex by EMSA using a 32P-labeled Lox 3'UTR probe. The position of the Lox complex (a doublet band) is shown in the first lane, and its sensitivity to poly(C) competition is demonstrated in the following lane. (B) Recruitment of CP into the Lox complex. Increasing concentrations of unlabeled Lox 3'UTR (wedge) were incubated with MEL S100 extract to form the Lox complex. The incubation mixtures were analyzed on native gels. The position of the uncomplexed CP in the S100 extract and its recruitment to the position of the Lox complex were visualized by Western analysis. (C) hnRNP K was not recruited into the Lox complex. hnRNP K was detected with a monospecific antibody. The study was carried out as described above.

CPs are sufficient for -complex formation. The above data suggested that CPs might be sufficient for -complex assembly without heterologous interacting proteins. To test this model, we examined whether recombinant CPs could directly interact with the 3'UTR. There are three predominant forms of CP in human and mouse cells: CP-1, CP-2, and the alternative-splicing product CP2-KL. The majority of reported CP cDNAs cloned to date lack an internal 93-bp exonic segment (CP2-KL splice variant [19]), and the CP2-KL isoform is the highest-frequency CP cDNA in the expressed sequence tag database (data not shown). The relative abundance of the mRNAs corresponding to the various CP isoforms was directly assessed in mouse (MEL) and human (K562) erythroid cell lines by an RT-PCR analysis. The RT-PCR primers corresponded to regions conserved in all known CP-1 and CP-2 sequences and bracketed the alternatively spliced central exons of the transcripts (see Materials and Methods). This combination of primers generated three cDNA products corresponding to the mRNAs encoding full-length CP-2 and CP-1 (top two bands) and the CP2-KL isoform (lower band) (Fig. 3A). The identity of each of these bands was confirmed by excision and sequencing (data not shown). The quantitative data for the mouse and human erythroid cells (Fig. 3B) revealed substantial levels of mRNA for each isoform, with predominance of CP2-KL mRNA in the MEL cells and a more equal distribution of the mRNAs encoding the three isoforms in the K562 cells. These mRNA data were consistent with the presence of all three protein isoforms in both human and mouse cells.

View larger version (37K): [in this window] [in a new window]   FIG. 3.   mRNA representation of mCP isoforms. (A) Autoradiograph of RT-PCR products. MEL RNA (left) or K562 RNA (right) was reverse transcribed and PCR-amplified by using primers that were perfect matches to all known CP mRNAs. The reverse primer was 32P end labeled. The reaction products were electrophoresed on a 2.5% MetaPhor agarose gel and quantified by PhosphoImager analysis. The identities of the cDNA fragments encoding CP-2, CP-1, and CP2-KL are as indicated and were confirmed by direct sequencing (not shown). (B) RT-PCR amplification kinetics. Relative quantities of the RT-PCR products representing each of the three CP mRNAs in MEL and K562 cells (left and right, respectively) were determined by PhosphorImager analysis. Logarithms of band intensities were plotted against the number of PCR cycles; these plots formed straight lines for the exponential phase of amplification, and the slopes reflect amplification efficiencies (67). The similarity in slopes for different CP isoforms shows that the efficiencies of their amplification were similar.

View larger version (52K): [in this window] [in a new window]   FIG. 4.   Direct, sequence-specific association of each of the recombinant CP isoforms with the 3'UTR. (A) Direct sequence-specific binding of recombinant CP2-KL to the -3'UTR. 32P-labeled 3'UTR (wild type [Wt]) or homologous RNAs containing specific sets of linker scanning base substitutions (H13, H19, and H23) that either disrupt (H13 and H19) or do not interfere (H23) with -complex formation (68, 70) were incubated with S100 extracts from K562 cells or MEL cells or with recombinant CP (CP2-KL). The complexes were digested with RNase T1 and applied to a native acrylamide gel. Lanes 1 and 2 represent the 3'UTR probe incubated without and with RNase T1, respectively. The subsequent lanes contain labeled RNA incubated with the indicated extracts. The position of the -complex is noted at the left. (B) Direct binding of recombinant CP-1 and CP-2 to the 3'UTR (determined as detailed for panel A). In each case, the complex was fully competed by added poly(C).

View larger version (37K): [in this window] [in a new window]   FIG. 5.   Direct association of recombinant CP2-KL with the 3'UTR-derived sequences from four highly stable mRNAs. [32P]RNA representing each of the following mRNAs was incubated with either MEL S100 extract (left) or recombinant CP2-KL (right): 3'UTR, PR, a poly(C) homoribopolymer (C17), the pyrimidine-rich 3'UTR segments of Lox, Coll, or TH, or a mutant 3'UTR (mut). An aliquot of each incubation mixture was subjected to native gel electrophoresis. The gel was then dried and autoradiographed. The wild-type -complex is shown in the second lane of each gel and is indicated by the arrow.

View larger version (44K): [in this window] [in a new window]   FIG. 6.   The -complexes formed with S100 extracts represent a heterogeneous population containing the three CP isoforms. (A) Selective detection of the three CP isoforms with epitope-specific antisera. Shown are results of Western analyses of recombinant CP-1, CP-2, and CP2-KL and of S100 extracts from mouse (MEL) or human (K562) erythroid cells probed with antisera specific for CP-1, CP-2, or an epitope shared by CP-2 and CP2-KL. (B) Supershift analysis of -complexes. [32P]3'UTR (lane 1) was incubated with K562 S100 extract and run on a native gel either alone (lane 3) or in the presence of increasing amounts of anti-CP-1 (lanes 4 and 5), anti-CP-2 (lanes 6 and 7), or antisera specific to CP-2 and CP2-KL (lanes 8 and 9). The native complex is composed of two subbands (upper [U] and lower [L]); the position of the antibody supershifted complex is indicated. Lane 2 contains probe digested with RNase prior to protein addition.

Recombinant CPs and cytosolic S100 extracts displayed similar RNA-binding affinities. The CP proteins are known to be targets of posttranslational modifications (34). Such modifications, which would not be present on the recombinant mCP produced in E. coli, might affect binding affinity (34). To detect such an effect, we determined the relative binding affinities of each of the purified recombinant CPs (Fig. 7). The amount of MEL S100 extract used in the study was normalized to its content of total CP by Western blotting and compared to an equivalent amount of recombinant protein (see Materials and Methods). Results of representative studies comparing CP2-KL with MEL S100 extract are shown in Fig. 7A and B. A constant amount of RNA (the 42-nt PR [see Materials and Methods]) of the 3'UTR as the RNA probe (see above) was incubated with increasing amounts of S100 extract or recombinant CP2-KL. The bound and free RNAs were then separated by EMSA and quantified, and free RNA probe concentrations were plotted versus total CP concentrations (Fig. 7C). The relative binding affinities of CPs in S100 extract or of recombinant CP2-KL were determined as the concentrations at which 50% of RNA was bound (10). The 50% binding concentration was in the same range for recombinant CP2-KL and S100 extract. Similar results were obtained when poly(C₁₇) homoribopolymer and full-length 3'UTR were used as RNA probes (data not shown); the binding affinities of recombinant CP2-KL and S100 for the RNA target were equivalent in each case.

View larger version (29K): [in this window] [in a new window]   FIG. 7.   Binding affinities of recombinant CPs and native cell extract for the 3'UTR. (A and B) RNA-binding affinities of proteins in the MEL S100 extract (A) and of recombinant CP2-KL (B). Increasing amounts of each were incubated with a fixed amount of [32P]PR probe. The amounts of CP2-KL in the recombinant preparation and in the S100 were normalized by Western blot analysis (see Materials and Methods). The free probe and complexed probe were separated by native gel electrophoresis and quantified. (C) Plot of binding. Results of both sets of experiments are shown; the concentrations of CP2-KL at which half of the probe is incorporated in the complex are indicated by the vertical arrows. (D) Apparent Kd (molar) for 3'UTR of each of the recombinant CP isoforms.

Sedimentation analysis of the -complex. The data detailed above demonstrated the sufficiency of CP2-KL for -complex assembly. As the CPs are capable of forming homodimers (references 19, 29, and 68a and our unpublished results), the stoichiometry of CPs in the -complex remained in question. The presence of multiple CP molecules and/or the presence of additional proteins in the complex would be directly reflected in its sedimentation characteristics during sucrose gradient centrifugation (Fig. 8). A ³²P-labeled -complex was assembled in vitro by incubating ([³²P]3'UTR) with MEL S100 cytosolic extract (68) (Fig. 8A, top). As expected, this complex was sensitive to poly(C) competition (Fig. 8A, top, second lane). The reaction mix was applied to a 5 to 20% sucrose gradient, and the sedimentation profile of the [³²P]-complex was determined by analysis of each gradient fraction on a native gel. The S100 extract assembled a single complex on the RNA target that sedimented just below the ovalbumin marker (ovalbumin M_r = 43,000, S = 3.66). A second gradient in which the [³²P]3'UTR was incubated with recombinant CP2-KL revealed a single peak complex in the same position (data not shown; see Fig. 8C). A third gradient containing S100 extract without added RNA probe (Fig. 8A, bottom) was run in parallel with these gradients. Western analysis of this gradient revealed that the uncomplexed CP sedimented at a position several fractions above the ovalbumin marker. From the standard curve (Fig. 8B), the sedimentation coefficients for CP and -complex were determined as 2.9 and 4.0, respectively. This difference in sedimentation between the -complex and the CP was consistent with the presence of the previously defined 42-nt (13-kDa) RNase T₁-resistant RNA fragment (22) bound to a single CP molecule. These data ruled out the presence of an CP dimer in the complex because such a complex would have sedimented well above the BSA (68-kDa) marker. Therefore, these studies were most consistent with an -complex containing a single molecule of CP.

View larger version (44K): [in this window] [in a new window]   FIG. 8.   Analysis of CP2-KL and the -complex sedimentation on 5 to 20% sucrose gradients. (A) Top, sedimentation analysis of the -complex and CP2-KL. 32P-labeled -complex was assembled by incubating [32P]3'UTR probe with MEL S100 extract. The gradients were centrifuged and fractionated as detailed in Materials and Methods. Aliquots of each fraction were analyzed on a native gel, and the 32P-labeled complex was detected by autoradiography. The first gel lane contained an aliquot of the loaded material. The position of the [32P]-complex is indicated by the bracket at the left, and its poly(C) sensitivity was confirmed in the second lane. Fraction numbers are noted below the lanes. Positions of the molecular weight markers run in a parallel gradient are indicated above the gradients. Bottom, MEL S100 with no added RNA probe. The gradient containing MEL S100 extract and no added RNA probe was run as described above. Gradient fractions were analyzed by SDS-PAGE, and CP was detected by Western blotting with chicken anti-CP antibody. Positions of molecular weight standards are indicated at the left. (B) Standard curve for sucrose gradient sedimentation. Positions of standards (see Materials and Methods) are indicated by the open circles. Positions of respective peak centers for CP2-KL and -complex are indicated by arrows. Sedimentation coefficients of standards, sw,20 (1013 s1), are also indicated. Ald, aldolase; Ova, ovalbumin; myo, myoglobin. (C) Sedimentation profiles of the -complexes assembled with S100 extract (top) or with recombinant CP2-KL (middle) compared with uncomplexed CP (bottom). Note identical sedimentation profiles of the native and recombinant -complexes and their positioning to the right of the uncomplexed CP.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

This present study was designed to establish the components and stoichiometry of the -complex. Previous studies of this complex have identified CPs as critical components of this complex (30). Multiple lines of investigation demonstrate that CPs can form protein-protein contacts with themselves and with a number of additional proteins (see the introduction). Contrary to expectations based on these previous reports, the data in the present study are most consistent with a simple binary composition of the -complex in which a single molecule of CP interacts with the 3'UTR. This conclusion is supported by several observations: (i) The absence of AUF1 and/or hnRNP K was directly demonstrated by an RNP recruitment assay. This approach revealed a quantitative and selective recruitment of CPs to the -complex independent of, and to the exclusion of, either of these other two proteins (Fig. 1 and 2). (ii) All three CP isoforms bound directly to the 3'UTR. This interaction demonstrated the same sequence specificity as that of the native S100 extract with respect to a set of informative 3'UTR mutants as well as for the 3'UTRs from three additional long-lived mRNAs (Fig. 4 and 5). (iii) The affinities (relative K_ds) of recombinant CPs for the 3'UTR were comparable (over a defined span) to that of the S100 extract (Fig. 7). (iv) The sedimentation characteristics of the -complex indicated that only a single molecule of an CP could be accommodated in the -complex (Fig. 8). These data effectively excluded the possibility that multiple molecules of CP cooperate in -complex formation. Taken together, these data support the conclusion of a 1:1 stoichiometry of an CP with the RNA target in the -complex.

The simple binary model for the -complex is at odds with the failure of our previous attempts to demonstrate direct binding of biochemically enriched cytosolic CP to the 3'UTR (30). These negative results might have reflected technical difficulties such as denaturation or partial degradation of CP during purification from the extract. Alternatively, the CPs may have undergone some sort of modification during isolation. It is well established, for example, that hyperphosphorylation of CPs can ablate binding activity (reference 34 and our unpublished data). However, the ability of the CP-enriched fractions to complement extracts depleted in poly(C) binding activity (30) renders these explanations unlikely and instead suggests additional variables in the assembly process. Future studies aimed at delineating the functional difference(s) between native and recombinant CP may therefore be informative.

We were unable to confirm the presence of AUF1 in the -complex as had been reported by others (29). Direct interaction of CP-1 and to a lesser extent CP-2 with AUF1 was initially documented by a yeast two-hybrid analysis and subsequently confirmed by glutathione S-transferase pull-down studies (29). However, evidence for actual coassembly of AUF1 with CPs in the context of the -complex was limited to AUF1 enrichment in the -complex region of a native gel after addition of target RNA to an S130 extract. While there are a number of technical differences between our study and this previous report in how the -complex was assembled and assayed, these differences are relatively minor. In this study, there was no evidence for incorporation of AUF1 into the -complex in the recruitment assay despite quantitative recruitment of CPs (Fig. 1D).

Previous studies by others have identified a multiple-repeat polypyrimidine tract in the Lox mRNA 3'UTR responsible for translational arrest of Lox mRNA during erythroid development (48). We subsequently reported that CP interacts with the single repeat unit of this pyrimidine-rich Lox mRNA determinant to form a complex that appears to be very similar to the -complex (22). More recently, studies suggested that in addition to CPs, the nuclear RNA binding protein hnRNP K also interacts with this region. Functional assays suggest that CP and hnRNP K mediate a cooperative suppression of Lox mRNA translation in vitro and in vivo. While our results (reference 22 and Fig. 2) agree that CP has the capacity to bind to the Lox 3'UTR, there was no evidence for significant incorporation of hnRNP K into the -complex. However these in vitro assays of RNA-protein interactions do not necessarily conflict with the prior report of a translation control effect by hnRNP K (48), as the underlying mechanism of such control may be unrelated to coassembly of hnRNP K with CP in a functional RNP complex.

Several observations indicate that -complex, and/or closely related CP-containing complexes, may represent a generally active mRNA stability determinant(s). CP proteins have a wide tissue distribution, and the -complex is formed from S100 extracts isolated from nonerythroid as well as erythroid cell lines (1, 19, 34). Furthermore, the CP-containing complex forms on the 3'UTR pyrimidine-rich elements of a subset of stable erythroid and nonerythroid mRNAs (13, 22, 47, 63). While these data suggest a general role of CP in mRNA metabolism, it is not clear how the -complex contributes to the longevity of target mRNAs. The binding of CP may be the initial event, serving to identify the target mRNAs. Subsequent involvement of additional proteins may then mediate interactions between the 3' and 5' ends of the mRNA to stabilize the mRNA, prevent endo- or exonuclease digestion, and/or direct the mRNA to a specific subcellular site. It has been recently reported that CP proteins can interact with poly(A) binding protein and that this interaction influences the rate of deadenylation in an in vitro system (68a). In vivo data from our own laboratory further supports a role of the poly(A) tail in the stabilization of h-globin mRNA (41). Subsequent interaction of poly(A) binding protein, possibly bound to an CP, with the translation initiation factor eIF4G (71) or a closely related homologue (PAIP [12]) may provide a physical link between the mRNA 5' and 3' termini. The delineation of the -complex as a binary complex should facilitate subsequent formulation of such testable models for the establishment of mRNA stabilization.